HIV Treatment Adds a Third One-a-Day Pill
HIV treatment adds a third one-a-day pill – Gilead Sciences’ one-pill-a-day HIV drug Quad is in the final phases of testing and could be approved by the FDA in August. If approved, Quad would become th…
HIV treatment adds a third one-a-day pill – Gilead Sciences’ one-pill-a-day HIV drug Quad is in the final phases of testing and could be approved by the FDA in August. If approved, Quad would become th…